SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending after a significant drop following mixed Phase 3 trial results, specifically related to high placebo response impacting statistical significance. The conversation centers on whether the sell-off is an overreaction given the company's cash reserves and ongoing pipeline, with some speculating about a potential buyout and others wary of the mixed data. Community members are actively discussing dip-buying strategies, potential bounce-back scenarios, and comparisons to competitor performance.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Shares of Robinhood are trending as the stock rallies to new all-time highs, fueled by optimism around its S&P 500 inclusion and growth in its prediction markets business; the community is closely watching for continued momentum. Several analysts have recently raised their price targets, with some traders speculating on further upside. The stock has become a favorite among millennial traders as it rides the crypto wave and wealth transfer megatrend.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

AUPH is trending due to a sharp drop in stock price following remarks made by a former FDA official, George Tidmarsh, regarding the drug Voclosporin. The community is expressing concerns about the validity and timing of the statement, with some suspecting market manipulation and questioning the company's leadership response. The drop has also impacted buyout hopes.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is trending following news of a partnership with Google to enhance AI-powered shopping experiences. While some investors are excited about the potential growth, others express frustration with the stock's historical underperformance and question whether the partnership will provide an immediate catalyst. Community members are debating whether this is a turning point or another false start for the fintech giant.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

MSOS is trending as cannabis stocks react to a video posted by Trump discussing the medical benefits of CBD for seniors, sparking community discussion around potential rescheduling.  Traders are actively weighing the implications of potential policy changes and the sector's volatile nature, while some highlight positive movement in European cannabis markets. The community speculates on the timing and impact of any official announcements.

Boqii Holding Ltd. operates as a holding company with interest in operating online pet stores. It provides services through its subsidiaries. The company was founded by Liang Hao, Tang Yingzhi, and Chen Di in December 2007 and is headquartered in Shanghai, China.

Boqii Holding Limited - Ordinary Shares - Class A

Boqii Holding Limited - ADR

Boqii Holding is trending due to speculation around a potential gamma squeeze and significant price movement, leading to community discussions about float size and potential price targets. Some traders are pointing to technical indicators and chart patterns, while others caution about the risks associated with Chinese stocks and potential pump-and-dump schemes. The stock's volatility and history of reverse splits are also prominent points of discussion among investors.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Shopify is trending following a strong earnings report, with revenue and GMV growth exceeding expectations. The community is discussing the company's resilience in the face of potential headwinds like tariffs, along with its expanding partnerships and AI initiatives. Bullish sentiment is fueled by raised price targets and the anticipation of continued growth, though some caution against overvaluation.

Bakkt Holdings, Inc. engages in the intersection of cryptoassets, loyalty and rewards, and payments. It also provides a platform to expand payment offerings, create new revenue streams, and increase customer loyalty. The company was founded in 2018 and is headquartered in Alpharetta, GA.

Bakkt Holdings Inc - Ordinary Shares - Class A

Bakkt Holdings Inc

Bakkt Holdings is trending due to renewed interest following news of a new board appointment, sparking discussions about the company's potential growth strategy within the digital asset space. The community is actively speculating about the impact of new leadership and potential partnerships, especially regarding expansion into foreign markets and web3 technologies. Bullish sentiment is building around the possibility of a short squeeze and the company's strengthened financial position after debt reduction.

Rezolve AI Plc operates in the mobile commerce industry with its cutting-edge engagement platform powered by artificial intelligence and machine learning. It develops AI-based mobile commerce and engagement solutions, simplifying the purchasing process by providing relevant information and facilitating seamless transactions with a single tap. The company enables retailers, brands, and manufacturers to create dynamic connections with consumers across mobile and desktop devices. Rezolve Ai was founded in 2016 and is headquartered in London, the United Kingdom.

Rezolve AI PLC .

Rezolve AI Limited

Rezolve AI ($RZLV) is trending amidst a short report from Fuzzy Panda Research, alleging inflated ARR and questionable partnerships, which the company has refuted. The community is fiercely debating the report's validity, with some viewing it as a buying opportunity ahead of earnings and others expressing concern. Bulls emphasize institutional investment and potential for high growth in the AI-powered commerce sector, while bears point to past financial performance and management's track record.

Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. The firm also conducts research in human metapneumovirus (hMPV) and SARS-CoV-2 (COVID-19). The company was founded by Peter O. Kliem Martin Karplus, James Hogle, Gerard Wagner, Peter M. Howley, and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.

Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals (ENTA) is trending due to mixed Phase 2b study results for its RSV treatment, zelicapavir, causing investor debate and a stock sell-off. While the primary endpoint was missed, secondary endpoints were met, fueling discussions about the drug's potential and Phase 3 progression, particularly regarding FDA priorities. Community talking points include potential short squeezes given the high short interest and oversold RSI.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

RPM International to Report Q1 Earnings: Here's What You Must Know 

Will RPM's Q1 results show steady growth as MAP 2025 savings, acquisitions and strong segment sales offset market softness?

Albemarle Corporation (ALB) is Attracting Investor Attention: Here is What You Should Know  

Albemarle (ALB) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Albemarle (ALB) Outpaces Stock Market Gains: What You Should Know

The latest trading day saw Albemarle (ALB) settling at $81.84, representing a +1.12% change from its previous close.

Zacks Industry Outlook Highlights DuPont de Nemours, Albemarle and Methanex

Chemical industry leaders are navigating global demand softness with strategic cost management, innovation, and capacity expansion to sustain growth.

Albemarle (ALB) Outperforms Broader Market: What You Need to Know

The latest trading day saw Albemarle (ALB) settling at $75.05, representing a +2.36% change from its previous close.

3 Diversified Chemical Stocks to Watch Amid Demand Worries

The Zacks Chemicals Diversified industry is hamstrung by weak demand in Europe, China and key end markets. DD, ALB and MEOH are poised to navigate the industry challenges.

Albemarle Corporation (ALB) Is a Trending Stock: Facts to Know Before Betting on It

Zacks.com users have recently been watching Albemarle (ALB) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Albemarle stock rose 25.2% in August, making the lithium miner the top gainer in the S&amp;P 500 index for the last month. Shares of the company, however, are not yet receiving a great deal of confidence from retail traders.The rally followed a statement by Chinese electric vehicle battery-making giant Contemporary Amperex Technology (CATL) on Aug. 11, which announced the suspension of operations at its Yichuan project due to the expiration of its mining license.With mining expected to remain shut for three months, according to CATL estimates, lithium prices have increased by over 30% in the past month. The rally has helped lithium miners recover some of the losses from earlier this year.Retail sentiment on Stocktwits about <a href="https://stocktwits.com/symbol/ALB">Albemarle</a>, the world's leading lithium producer, was still in the ‘bearish’ territory at the time of writing.<figure class="image"><img style="aspect-ratio:791/94;" src="https://news.stocktwits-cdn.com/ALB_Sept_1_JPG_8199582749.webp" alt="ALB’s Sentiment Meter and Message Volume as of 10:03 p.m. ET on Sept. 1, 2025 | Source: Stocktwits" width="791" height="94"><figcaption>ALB’s Sentiment Meter and Message Volume as of 10:03 p.m. ET on Sept. 1, 2025 | Source: Stocktwits</figcaption></figure>The stock has seen only a 7% rise in retail watcher count on Stocktwits over the past year, and a modest 0.8% increase in August, with message volume in the ‘low’ zone as of the last reading.Despite the surge in shares, some Wall Street analysts remain unconvinced about its long-term appeal. “We had originally viewed many of these announcements as temporary and due to one-offs, but we also recognize a growing expectation of lasting curtailments given continued increases in lithium price,” Baird analyst Ben Kallo noted last week.Kallo raised the price target of the stock to $68 from $58, but maintained a ‘Sell’ rating on the stock. “We still have limited visibility in market dynamics and government policy within China, but we are raising our price target to reflect the pricing move,” he said.Year-to-date, Albemarle shares are still down 1.8%, as lithium prices plunged well below 2022 highs. The company has already paused a key refinery project in the U.S. and has seen several rounds of layoffs over the past year.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/yd-bio-stock-fuels-retail-trader-excitement-after-nasdaq-listing-through-breeze-spac-deal/chv69TURdVp">YD Bio Stock Fuels Retail-Trader Excitement After Nasdaq Listing Through Breeze SPAC Deal</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

 In this photo illustration, a smartphone displays the logo of Albemarle Corporation (NYSE: ALB). 

Lithium Miner Albemarle Outshines S&P 500 With 26% Surge In August — But Wall Street, Retail Traders Still Not Fully Convinced

The rally followed a statement by China's CATL, which announced the suspension of operations at its Yichuan project.

Equity

Why Is Albemarle (ALB) Up 25.2% Since Last Earnings Report?

Albemarle (ALB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Investors Heavily Search Albemarle Corporation (ALB): Here is What You Need to Know

Recently, Zacks.com users have been paying close attention to Albemarle (ALB). This makes it worthwhile to examine what the stock has in store.

Albemarle Corp. engages in the development, manufacture, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. It operates through the following segments: Energy Storage, Specialties, Ketjen, and All Other. The Energy Storage segment develops and manufactures a broad range of basic lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride. The Specialties segment focuses on optimizing a portfolio of bromine and specialized lithium solutions. The Ketjen segment consists of clean fuels technologies, fluidized catalytic cracking catalysts and additives, and performance catalyst solutions, which is primarily composed of organometallics and curatives. The All Other segment refers only to the FCS business that did not fit into any of the company’s core businesses. The company was founded in 1993 and is headquartered in Charlotte, NC.

Current Price	$87.21
Prev Close	$88.10
Open	$90.50
Dividend Yield	1.87%
50-Day Moving Average	$78.61
Beta	1.66
Avg. Volume	4.11M
PE Ratio	-9.45

52-Week High	$113.91
52-Week Low	$49.43
Market Capitalization	$10.37B
EPS (Annual)	-$11.20
Price to Book	1.29
Revenue Per Employee	$647,894.70
Enterprise Value/EBITDA	N/A

ALB
Albemarle Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ALB News

ALB Albemarle Corp